Home
Neurocrine Biosciences NBIX spent $940K on lobbying in Q1 2026 · Taxation, Medicare and 2 more issues
Trade details
- Type
- Lobbying report
- Amount
- $940,000
- Quarter
- Q1 2026
- Client
- Neurocrine Biosciences
- Reported
- 26/04/20
Up 4.4% from last quarter
What else happened in Neurocrine Biosciences around then
Filed or reported within 30 days of the trade day · 03/01~04/30Neurocrine Biosciences's other lobbying reports
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$60K
$60K
Reported 07/20
for Q2
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$110K
$110K
Reported 07/20
for Q2
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$940K
$940K
Reported 07/20
for Q2
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$60K
$60K
Reported 07/08
for Q2
- Neurocrine Biosciences
LobbyingNeurocrine Biosciences
LobbyingNeurocrine Biosciences
NBIX
$80K
$80K
Reported 04/20
for Q1